Search results
Dr. Adrian Blaser. 0000-0002-9565-6445. Senior Research Fellow. Auckland Cancer Society Research Centre. +6493737599 Ext.88228 (Work) +64212327998 (Mobile) a.blaser@auckland.ac.nz. M&HS BUILDING 504 - Bldg 504, 85 PARK RD, GRAFTON, AUCKLAND, 1023, New Zealand. Collaboration Network. Apply To Study. Are you Adrian Blaser? Edit your profile.
View Adrian Blaser’s profile on LinkedIn, a professional community of 1 billion members. Senior Researcher at the University of Auckland; Honorary Consul at Consulate of Switzerland ·...
- The University of Auckland
View the profiles of people named Adrian Blaser. Join Facebook to connect with Adrian Blaser and others you may know. Facebook gives people the power to...
Adrian BLASER, Senior Researcher, NMR Manager | Cited by 1,037 | of University of Auckland, Auckland | Read 34 publications | Contact Adrian BLASER
Sep 22, 2017 · It demonstrates excellent efficacy against TB but induces phospholipidosis at high doses, has a long terminal elimination half-life (due to its high lipophilicity), and exhibits potent hERG channel inhibition, resulting in clinical QTc interval prolongation.
- Amy S. T. Tong, Peter J. Choi, Adrian Blaser, Hamish S. Sutherland, Sophia K. Y. Tsang, Jerome Guill...
- 2017
ORCID record for Adrian Blaser. ORCID provides an identifier for individuals to use with their name as they engage in research, scholarship, and innovation activities.
May 1, 2018 · Abstract. Replacing the naphthalene C-unit of the anti-tuberculosis drug bedaquiline with a range of bicyclic heterocycles of widely differing lipophilicity gave analogs with a 4.5-fold range in clogP values.
